|Articles|January 12, 2011

Are College Students Getting Sicker? No, Diagnoses Change Faster Than People

Author(s)Allen Frances, MD, Allen Frances, MD

The New York Times of Dec 20,2010 carried an alarming story. It seems that during the past decade, college students have suddenly become much more mentally ill.

Array

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Future DSM Plans Overlook Core Problem of Validity

ByS. Nassir Ghaemi, MD, MPH,Mark L. Ruffalo, MSW, DPsa

July 20th 2026

New Name, New Path for Psychiatry: The Future of the DSM

ByJonathan E. Alpert, MD, PhD

June 2nd 2026

Envisioning a New Diagnostic Manual: Insights From the Vice Chair of the Future DSM Strategic Committee

ByJonathan E. Alpert, MD, PhD

June 2nd 2026

Future DSM Repeats Past Mistakes: Validity Is Ignored

ByS. Nassir Ghaemi, MD, MPH,Mark L. Ruffalo, MSW, DPsa

May 29th 2026

Psychiatry Does Not Need a Softer DSM. It Needs a Smarter One.

ByGarrett Rossi, MD

April 30th 2026

Latest CME

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Are College Students Getting Sicker? No, Diagnoses Change Faster Than People

Related Content

Future DSM Plans Overlook Core Problem of Validity

New Name, New Path for Psychiatry: The Future of the DSM

Envisioning a New Diagnostic Manual: Insights From the Vice Chair of the Future DSM Strategic Committee

Future DSM Repeats Past Mistakes: Validity Is Ignored

Psychiatry Does Not Need a Softer DSM. It Needs a Smarter One.

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Trending on Psychiatric Times

Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation

Future DSM Plans Overlook Core Problem of Validity

Crisis Management and Care Planning in Schizophrenia

Optimizing Care Transitions and Access in Schizophrenia Management

Assessing Antipsychotics as Antidepressant Adjuncts